ClinicalTrials.gov
public full text
Public Domain
Control and Elimination Within Australia of Hepatitis C From People Living With HIV
The purpose of this study is to evaluate the feasibility of rapid scale-up of new hepatitis C (HCV) treatments, known as interferon-free Direct Acting Antiviral (DAA) drugs, and impact on the proportion of people with HCV within the HIV-HCV coinfected population of Australia. It is hypothesised that a rapid scale-up of hepatitis C treatment with interferon-free therapies in individuals with HIV-HCV coinfection will assist in controlling HCV infection in this population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Infektiosität von Hepatitis-B-Virus Genotyp F- und H-pseudotypisierten Hepatitis-Delta-Viren und deren Neutralisierbarkeit durch humane und tierische Impfseren nach Hepatitis-B-Impfung#206050
- Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana#274855
- Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya#847185
- Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa#1172986
- Using PrEP, Doing It for Ourselves#894152
Record · ID 803563
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive